Lazard Asset Management’s Entrada Therapeutics TRDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
2025
Q2
$8K Sell
2025
Q1
$358K Sell
2024
Q4
$959K Buy
2024
Q3
$630K Buy
2024
Q2
$43K Buy
2024
Q1
$2K Sell
2023
Q4
$40K Buy
2023
Q3
Sell
2023
Q2
$36K Buy